Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Immunology and Allergy Clinics of North America|April 26, 2025
Biomarkers of Immune Dysregulation and What They Tell Us: Gene Sequencing Is Not the Answer to Every QuestionThinh H Nguyen, Shanmuganathan Chandrakasan
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 7, 2025
Urbanization and childhood asthmaTeresia T Pham, Yeside Akinbolagbe, Thinh H Nguyen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 11, 2025
Optimizing Pediatric Asthma Management: Implementation and Evaluation of Anti-Inflammatory Reliever and Single Maintenance and Reliever TherapiesThinh H Nguyen, Megan Elios, Anne M Fitzpatrick, et al.
Molecular Cancer Therapeutics|January 26, 2017
Reactive Oxygen Species-Mediated Synergism of Fenretinide and Romidepsin in Preclinical Models of T-cell Lymphoid MalignanciesMonish R Makena, Balakrishna Koneru, Thinh H Nguyen, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2026
Predicting Asthma Prevalence Across U.S. Communities by Integrating Social Vulnerability and Environmental Risk with Machine LearningThinh H Nguyen, Saleh Alsulami, Teresia T Pham, et al.
Medicine|October 4, 2018
Von Hippel-Lindau with early onset of hemangioblastoma and multiple drop-metastases like spinal lesions: A case reportThinh H Nguyen, Teresia Pham, Thea Strickland, et al.
The Journal of Allergy and Clinical Immunology|July 12, 2024
Implementing a clinical decision support tool to increase early peanut introduction guidanceAnnabelle F Rowland, Thinh H Nguyen, Priscila P Cunha, et al.
Nature Medicine|July 3, 2026
Generalizable AI predicts immunotherapy outcomes across cancers and treatmentsWanxiang Shen, Intae Moon, Thinh H Nguyen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Generalizable AI predicts immunotherapy outcomes across cancers and treatmentsWanxiang Shen, Thinh H Nguyen, Michelle M Li, et al.
Anti-Cancer Drugs|December 16, 2020
The O6-methyguanine-DNA methyltransferase inhibitor O6-benzylguanine enhanced activity of temozolomide + irinotecan against models of high-risk neuroblastomaAshly Hindle, Balakrishna Koneru, Monish Ram Makena, et al.
Pageof 3